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ABSTRACT
Hydrogen sulfide (H2S) is an endogenous gaseous mediator that has gained increasing recognition as an important player in
modulating acute and chronic inflammatory diseases. However, its role in virus-induced lung inflammation is currently un-
known. Respiratory syncytial virus (RSV) is a major cause of upper and lower respiratory tract infections in children for which
no vaccine or effective treatment is available. Using the slow-releasing H2S donor GYY4137 and propargylglycin (PAG), an in-
hibitor of cystathionine--lyase (CSE), a key enzyme that produces intracellular H2S, we found that RSV infection led to a re-
duced ability to generate andmaintain intracellular H2S levels in airway epithelial cells (AECs). Inhibition of CSE with PAG re-
sulted in increased viral replication and chemokine secretion. On the other hand, treatment of AECs with the H2S donor
GYY4137 reduced proinflammatory mediator production and significantly reduced viral replication, even when administered
several hours after viral absorption. GYY4137 also significantly reduced replication and inflammatory chemokine production
induced by humanmetapneumovirus (hMPV) and Nipah virus (NiV), suggesting a broad inhibitory effect of H2S on paramyxo-
virus infections. GYY4137 treatment had no effect on RSV genome replication or viral mRNA and protein synthesis, but it inhib-
ited syncytium formation and virus assembly/release. GYY4137 inhibition of proinflammatory gene expression occurred by
modulation of the activation of the key transcription factors nuclear factor B (NF-B) and interferon regulatory factor 3
(IRF-3) at a step subsequent to their nuclear translocation. H2S antiviral and immunoregulatory properties could represent a
novel treatment strategy for paramyxovirus infections.
IMPORTANCE
RSV is a global health concern, causing significant morbidity and economic losses as well as mortality in developing countries.
After decades of intensive research, no vaccine or effective treatment, with the exception of immunoprophylaxis, is available for
this infection as well as for other important respiratory mucosal viruses. This study identifies hydrogen sulfide as a novel cellular
mediator that canmodulate viral replication and proinflammatory gene expression, both important determinants of lung injury
in respiratory viral infections, with potential for rapid translation of such findings into novel therapeutic approaches for viral
bronchiolitis and pneumonia.
Hydrogen sulfide (H2S) is an endogenous gaseous transmitterthat participates in the regulation of the respiratory system’s
physiological functions and pathophysiological alterations, in-
cluding chronic obstructive pulmonary disease (COPD), asthma,
pulmonary fibrosis, and hypoxia-induced pulmonary hyperten-
sion, as it regulates lung functions such as airway constriction,
pulmonary circulation, cell proliferation/apoptosis, fibrosis, oxi-
dative stress, and inflammation (reviewed in reference 1). H2S is
produced endogenously inmammals, including humans, by three
enzymes: cystathionine--lyase (CSE), cystathionine--synthase
(CBS), and 3-mercaptopyruvate sulfurtransferase (MST) (2–4).
Sulfide salts such as sodium hydrosulfide (NaHS) and sodium
sulfide (Na2S) have beenwidely used to study the biological effects
of hydrogen sulfide inmany cells, tissues, and animals. These salts
generate a large burst of H2S over a short time period, when used
in cell culture. GYY4137 is a novel water-soluble H2S donor that
releases H2S slowly over a period of hours (5). H2S donors have
been used to demonstrate how therapeutic H2S administration
exerts significant effects on various animal models of inflamma-
tion, reperfusion injury, and circulatory shock (6). There are no
studies investigating the role of H2S generation in pathophysiol-
ogy of viral infections or the use of H2S donors as a pharmacolog-
ical intervention for virus-induced diseases.
Respiratory tract infections are a leading cause of morbidity
and mortality worldwide. Paramyxoviruses, which include respi-
ratory syncytial virus (RSV) and human metapneumovirus
(hMPV), represent a major cause of pediatric upper and lower
respiratory tract infections (7, 8). These viruses are associatedwith
bronchiolitis, pneumonia, flu-like syndromes, as well as asthma
exacerbations and represent a substantial public health problem
for the community. Nipah virus (NiV) is a zoonotic emerging
pathogen that also belongs to the Paramyxoviridae family and can
cause severe and often fatal respiratory disease and/or encephalitis
in humans (9). No vaccine or effective treatment is available for
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RSV, hMPV, or NiV, with the exception of immunoprophylaxis
for RSV. Our previous studies have shown that these viruses in-
duce the expression of a variety of proinflammatory genes, includ-
ing cytokines and chemokines, in airway epithelial cells (AECs),
the main target of infection (10–12), which are likely to play a
major role in disease pathogenesis. Cytokine and chemokine gene
expression in virus-infected cells is orchestrated by the activation
of two key transcription factors, nuclear factor B (NF-B) and
interferon regulatory factor 3 (IRF-3). A number of virus-induc-
ible inflammatory and immunoregulatory genes require NF-B
for their transcription and/or are dependent on an intact NF-B
signaling pathway (13, 14), and IRF-3 is necessary for viral induc-
tion of RANTES transcription and gene expression (15, 16).
To address the role of H2S generation/administration in viral
infections, we used an in vitromodel of RSV infection ofAECs.We
found that RSV infection led to decreased expression of CSE, a
reduced ability to generate cellular H2S, as well as increased H2S
degradation. Inhibition of H2S generation by using PAG was as-
sociated with increased generation of virus infectious particles as
well as increased proinflammatory mediator secretion, suggesting
an important role of endogenous H2S in controlling viral replica-
tion and proinflammatory gene expression. GYY4137 treatment
of both A549 (a lung carcinoma cell line retaining features of type
II alveolar epithelial cells) and primary small alveolar epithelial
(SAE) cells significantly reduced virus-induced proinflamma-
tory mediator release, and it significantly inhibited viral repli-
cation at a step subsequent to viral adsorption. GYY4137 ad-
ministration blocked RSV replication without significantly
reducing viral mRNA synthesis, viral genome replication, and
viral protein synthesis, indicating that it affects steps involved
in viral assembly and/or release. It also resulted in significant
inhibition of syncytium formation, indicating a modulatory
effect on virus-induced cellular fusion.
GYY4137 treatment of AECs infected with RSV did not affect
the initial step of virus-induced activation of IRF-3 and NF-B, as
shown by the lack of changes in their nuclear translocation; how-
ever, it significantly reduced IRF-3 and NF-B binding to the en-
dogenous promoter of proinflammatory genes, resulting in an
inhibition of chemokine gene transcription, indicating an impor-
tant effect of H2S on cellular signaling, independent of its antiviral
activity.
MATERIALS AND METHODS
Materials. GYY4137 [morpholin-4-ium-4-methoxyphenyl(morpholino)
phosphinodithioate], a novel water-soluble, slow-releasing H2S com-
pound, and DL-propargylglycin (PAG), an inhibitor of theH2S-generating
enzyme cystathionine--lyase (CSE), were purchased from Sigma-Al-
drich (St. Louis, MO, USA). Solutions were prepared freshly in culture
medium and filtered through a 0.2-m filter before treatment. Sulfide-
fluor-7-acetoxymethyl ester (SF7-AM), a fluorescent probe that allows
direct, real-time visualization of endogenousH2S produced in live human
cells (17), was generously provided by Christopher J. Chang (Department
of Chemistry, University of California, Berkeley). An SF7-AM stock solu-
tion was prepared in dimethyl sulfoxide (DMSO) and diluted in serum-
free medium at least a thousandfold.
Virus preparation. The RSV Long strain was grown in HEp-2 cells
and purified by centrifugation on discontinuous sucrose gradients, as de-
scribed previously (18, 19), and titers of viral pools in PFU/ml were de-
termined by using a methylcellulose plaque assay, as described previously
(20). No contaminating cytokines or lipopolysaccharide (LPS), tested by
the Limulus hemocyanin agglutination assay, was found in these virus
preparations. Virus pools were aliquoted, quick-frozen on dry ice-alco-
hol, and stored at80°C until use.
hMPV strain CAN97-83 was obtained from the Centers for Disease
Control and Prevention (CDC), Atlanta, GA, with permission from Guy
Boivin at the Research Center in Infectious Diseases, Regional Virology
Laboratory, Laval University, Quebec City, Canada; propagated on LLC-
MK2 cells; and purified on sucrose cushions, as previously described (21).
Titers of virus pools in PFU/ml were determined by immunostaining, as
previously described (21).
The Nipah virus Bangladesh strain (NiV-B) was obtained from the
Special Pathogens Branch of the Centers for Disease Control and Preven-
tion (Atlanta, GA). The virus was propagated on Vero cells, as previously
described (10). Titers of virus pools were determined by a 50% tissue
culture infective dose (TCID50) assay, as previously described (10). All
infectious work with NiV was performed in a class II biological safety
cabinet in a biosafety level 4 (BSL4) laboratory at the Galveston National
Laboratory.
Cell culture and viral infection. A549 cells, a human alveolar type
II-like epithelial cell line (American Type Culture Collection, Manassas,
VA), and small alveolar epithelial (SAE) cells (Clonetics, San Diego, CA),
derived from terminal bronchioli of cadaveric donors, were grown in
F12Kmediumand SAE cell growthmedium, respectively, containing 10%
(vol/vol) fetal bovine serum (FBS), 10 mM glutamine, 100 IU/ml penicil-
lin, and 100g/ml streptomycin for F12Kmedium and 7.5mg/ml bovine
pituitary extract (BPE), 0.5 mg/ml hydrocortisone, 0.5g/ml human epi-
dermal growth factor (hEGF), 0.5mg/ml epinephrine, 10mg/ml transfer-
rin, 5 mg/ml insulin, 0.1g/ml retinoic acid, 0.5g/ml triiodothyronine,
50 mg/ml gentamicin, and 50 mg/ml bovine serum albumin (BSA) for
SAE cell medium.When SAE cells were used for RSV infection, they were
changed to basal medium, not supplemented with growth factors, 6 h
prior to and throughout the experiment. Confluent cell monolayers were
infected with RSV or hMPV at multiplicity of infection (MOI) of 1, as
previously described (22), unless otherwise stated. NiV infection was per-
formed at an MOI of 0.01 (10). For PAG experiments, cells were seeded
into 6-well or 24-well plates, infected with RSV for 1 h at 37°C in 5%CO2,
and then treated with PAG after the viral inoculum was removed. For
GYY4137 experiments, cells were seeded into 6-well or 24-well plates and
treated either prior to infection, but not throughout the duration of in-
fection, or at different times postinfection (p.i.), after the viral inoculum
was removed. There was no effect of either compound on uninfected-cell
viability, as assessed by trypan blue exclusion, or on basal cellular media-
tor secretion.
Methylene blue assay.H2S production was measured by use of a col-
orimetric methylene blue assay, as previously described (23). Briefly, cells
were homogenized, incubated at 37°C for 5 min, and then cooled on ice
for 10min. L-Cysteine (1 and 3mmol/liter) and pyridoxal 5-phosphate (2
mmol/liter) were added and incubated for 1 h at 37°C. Zinc acetate (1%)
and 10% trichloroacetic acid solutions were used to terminate the reac-
tion. After the addition of N,N-dimethylphenylendiamine sulfate and
FeCl3 for 15 min, the optical absorbance of the solutions was measured at
650 nm.
SF7-AM fluorescence assay.A549 cells were grown in eight-well Lab-
Tek II glass chamber slides (Thermo Scientific, Pittsburgh, PA, USA) and
incubated with 5 M SF7-AM probe at 37°C for 30 min. After washing
with culture medium, A549 cells were infected with RSV and treated with
GYY4137, as described above. Confocal fluorescence imaging studies
were performed with a Zeiss 710 laser scanning microscope with a 20
water objective lens, with Zen 2009 software (Carl Zeiss). SF7-AM was
excited by using a 488-nm argon laser, and emission was collected by
using a Meta detector at wavelengths of between 500 and 650 nm. Cells
were imaged at 37°C with 5% CO2 throughout the experiment. Image
analysis was performed by using Metamorph software (Carl Zeiss), and
fluorescence was quantified by using the mean pixel intensity after setting
a common threshold for all images.
Li et al.
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Luciferase assay. A549 cells were transiently transfected by using a
NF-B- or interferon-stimulated responsive element (ISRE)-driven lucif-
erase reporter plasmid containing five repeats of the NF-B site of the IgG
promoter or three repeats of the RANTES ISRE promoter, respectively,
linked to the luciferase reporter gene, using Fugene 6 (Roche Diagnostic
Corp., Indianapolis, IN), as previously described (16, 24). A total of 0.5g
of the reporter gene plasmid and 0.05 g of -galactosidase expression
plasmid/well were premixed with Fugene 6 and added to the cells in reg-
ular medium. The next day, cells were infected with RSV for 1 h, followed
by treatment with GYY4137, and harvested at either 15 or 24 h p.i. to
independently measure luciferase and -galactosidase reporter activities,
as previously described (24). Luciferase activity was normalized to the
activity of the internal control -galactosidase. Results are expressed in
arbitrary units.
Determination of lactate dehydrogenase activity. Lactate dehydro-
genase (LDH) activity in the medium, an index of cellular damage, was
measured by a colorimetric assay using a commercially available kit (Cay-
man Chemical, MI, USA) according to the manufacturer’s instructions.
Quantitative real-time PCR. Total RNA was extracted by using a
ToTALLYRNAkit (catalog numberAM1910; Ambion, Austin, TX). RNA
samples were quantified by using a NanoDrop spectrophotometer
(Thermo Fisher Scientific Inc., Wilmington, DE), and quality was ana-
lyzed on an RNANano or Pico chip by using the Agilent 2100 bioanalyzer
(Agilent Technologies). Synthesis of cDNA was performed with 1 g of
total RNA in a 20-l reaction mixture by using the TaqMan Reverse
TranscriptionReagents kit fromABI (catalog numberN8080234; Applied
Biosystems). The reaction conditions were as follows: 25°C for 10 min,
48°C for 30 min, and 95°C for 5 min. Quantitative real-time PCR ampli-
fication (performed in triplicate) was done with 1 l of cDNA in a total
volume of 25 l by using Faststart Universal SYBR green master mix
(catalog number 04913850001; Roche Applied Science). The final con-
centration of the primers was 300 nM. 18S RNAwas used as a housekeep-
ing gene for normalization. PCR assays were run with the ABI Prism 7500
sequence detection system with the following conditions: 50°C for 2 min,
95°C for 10 min, and then 95°C for 15 s and 60°C for 1 min for 40 cycles.
The RSV N-specific reverse transcriptase (RT) primer contained a tag
sequence from the bacterial chloramphenicol resistance (Cmr) gene to
generate the cDNA, because of self-priming exhibited by RSV RNA. Du-
plicate cycle threshold (CT) values were analyzed inMicrosoft Excel by the
comparativeCT (CT)method according to themanufacturer’s instruc-
tions (Applied Biosystems). The amount of target (2CT) was obtained
by normalization to the endogenous reference (18S) sample. To detect
RSV N transcripts, we used RT primer 5=-CTGCGATGAGTGGCAGGC
TTTTTTTTTTTTAACTCAAAGCTC-3=; the tag is underlined. For PCR
assays, we used RSV tag reverse primer CTGCGATGAGTGGCAGGC and
forward primer ACTACAGTGTATTAGACTTRACAGCAGAAG. To de-
tect the genome minus strand, we used RSV N RT primer 5=-CTGCGAT
GAGTGGCAGGCACTACAGTGTATTAGACTTRACAGCAGAA
G-3=. For PCR assays, we used RSV tag primer CTGCGATGAGTGGC
AGGC and primer RSV P GCATCTTCTCCATGRAATTCAGG.
Western blotting. Nuclear extracts of uninfected and infected cells
were prepared by using hypotonic/nonionic detergent lysis, according to a
protocol described previously by Schreiber et al. (25). To prevent contam-
ination with cytoplasmic proteins, isolated nuclei were purified by cen-
trifugation through 1.7M sucrose buffer for 30min at 12,000 rpm, before
nuclear protein extraction, as previously described (26). Total cell lysates
were prepared from uninfected and infected A549 cells by the addition of
ice-cold lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM
EGTA, 0.25% sodium deoxycholate, 1 mMNa3VO4, 1 mMNaF, 1% Tri-
ton X-100, and 1 g/ml of aprotinin, leupeptin, and pepstatin). After
incubation on ice for 10 min, the lysates were collected, and detergent-
insoluble materials were removed by centrifugation at 4°C at 14,000 g.
Proteins (10 to 20g per sample) were then boiled in 2 Laemmli buffer
and resolved on SDS-PAGEgels. Proteinswere transferred onto aHybond
polyvinylidene difluoride membrane (Amersham, Piscataway, NJ), and
nonspecific binding sites were blocked by immersing the membrane in
Tris-buffered saline–Tween (TBST) containing 5% skim milk powder or
5% bovine serum albumin for 30 min. After a short wash in TBST, mem-
branes were incubated with the primary antibody for 1 h at room temper-
ature or overnight at 4°C, depending on the antibody used, followed by
incubationwith horseradish peroxidase (HRP)-conjugated secondary an-
tibody (Sigma, St. Louis, MO), diluted 1:10,000 in TBST, for 30 min at
room temperature. After washing, proteins were detected by using an
enhanced chemiluminescence system (RPN2016; Amersham,GEHealth-
care, United Kingdom) and visualized by autoradiography. Antibodies
used forWestern blot assayswere goat anti-RSVpolyclonal antibody from
Ab D SeroTec; rabbit anti-p65, anti-Ser536, or anti-Ser276 p65 from Cell
Signaling Technology Inc., Danvers, MA; and rabbit anti-IRF-3 from
Santa Cruz Biotechnology, Santa Cruz, CA.
Bio-Plex assay. Cell-free supernatants were tested for multiple cyto-
kines and chemokines by using the Bio-Plex Cytokine Human multiplex
panel (Bio-Rad Laboratories, Hercules, CA), according to the manufac-
turer’s instructions. Interleukin-8 (IL-8) and RANTES were also quanti-
fied by an enzyme-linked immunosorbent assay (ELISA) according to the
manufacturer’s protocol (DuoSet; R&D Systems, Minneapolis, MN).
Prior to analysis, NiV samples were inactivated on dry ice by gamma
radiation (5 megarads).
Chromatin immunoprecipitation and quantitative genomic PCR.
For chromatin immunoprecipitation (ChIP) assays, we used a ChIP-It
express kit from Active Motif (Carlsbad, CA) according to the manufac-
turer’s instructions, with some modifications. Briefly, A549 cells in a
10-cm plate were washed three times with phosphate-buffered saline
(PBS) and fixed with freshly prepared 2 mM disuccinimidyl glutarate
(DSG) for 45min at room temperature. After three washes with PBS, cells
were fixedwith freshly prepared formaldehyde for 10min and neutralized
with glycine for 5 min at room temperature. Cells were harvested and
disrupted by using a Dounce homogenizer to isolate nuclei. Nuclei were
sheared by sonication to obtain DNA fragments of 200 to 1,500 bp.
Twenty micrograms of sheared chromatin was immunoprecipitated with
5 g of ChIP-grade anti-NF-B (catalog number sc-722X) or anti-IRF-3
(catalog number sc-369X) antibodies fromSanta Cruz Biotechnology and
magnetic beads conjugated with protein G at 4°C overnight. Immunopre-
cipitation with IgG antibody was used as a negative control. Chromatin
was reverse cross-linked, eluted from magnetic beads, and purified by
using aQiagenPCRpurification kit (Qiagen,USA).Quantitative genomic
PCR (Q-gPCR) was done by SYBR green-based real-time PCR using
primers spanning the IL-8 gene NF-B promoter site (forward primer
AGGTTTGCCCTGAGGGGATG and reverse primer GGAGTGCTCCG
GTGGCTTTT) or primers spanning the RANTES gene ISRE promoter
site (forward primer AGCGGCTTCCTGCTCTCTGA and reverse primer
CAGCTCAGGCTGGCCCTTTA). Total input chromatin DNA for im-
munoprecipitation was included as a positive control for PCR amplifica-
tion.
Statistical analysis. Statistical analyseswere performedwith the InStat
3.05 Biostatistics package from GraphPad, San Diego, CA. To ascertain
differences between two groups, Student’s t test was used, and if more
than two groups were compared, one-way analysis of variance was per-
formed, followed by Tukey’s post hoc test. P values of	0.05 were consid-
ered statistically significant. When indicated, values of measurements are
expressed as means
 standard errors of the means (SEM) in the figures.
RESULTS
RSV infection affects H2S generation in airway epithelial cells.
Of the three H2S-generating enzymes CSE, CBS, and MST, CSE
represents the major source of H2S in lung tissue, and it uses
cysteine as the main substrate. Sulfide:quinone oxidoreductase
(SQOR) is amembrane-bound enzyme that catalyzes the first step
in the mitochondrial metabolism of H2S (27). To determine
whether RSV induced changes in H2S-generating and -metaboliz-
ing enzymes in AECs, A549 cells were infected for 6, 15, and 24 h
RSV and H2S
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and harvested for extraction of total RNA and measurement of
CSE, CBS, and SQOR mRNA levels by real-time PCR. We found
that CSE mRNA and protein expression levels were decreased by
RSV infection only at later time points (Fig. 1A), while there was
no significant change in the CBS mRNA level (data not shown).
On the other hand, there was a significant time-dependent in-
crease in the SQOR mRNA expression level in RSV-infected cells
compared to uninfected cells (Fig. 1C). To investigate whether
RSV modulated the capacity of airway epithelial cells to generate
H2S, A549 cells were infected for 15 h and harvested to prepare
total cell lysates. H2S production was then measured by a methyl-
ene blue assay. Therewas a significant reduction inH2S generation
in RSV-infected cells, compared to uninfected cells, when cysteine
was supplied at 1 and 3 mM concentrations as the CSE substrate
(Fig. 1B). When A549 cells were treated with the slow-releasing
H2S donor GYY4137, there was a significant increase in the intra-
cellular level of H2S detected by the fluorescent probe SF7-AM,
which was significantly lower in infected cells, suggesting an in-
crease in H2S degradation following RSV infection (Fig. 1D).
CSE inhibition enhances RSV-induced chemokine produc-
tion andviral replication.To examine the effect ofCSE inhibition
on virus-induced cellular responses, A549 cells were infected with
RSV for 1 h and then treated with different concentrations of
DL-propargylglycin (PAG). Cell supernatants were harvested at 24
h p.i. to measure virus-induced chemokine secretion. PAG ad-
ministration significantly increased the levels of production of
several cytokines and chemokines in response to RSV infection in
a dose-dependent manner (Fig. 2A). PAG treatment of A549 cells
also resulted in a significant increase in viral infectious-particle
formation (3- to 4-fold increase), assessed by a plaque assay (Fig.
2B), indicating a role of endogenous H2S production in viral rep-
lication and proinflammatory cellular responses.
Effect of H2S treatment on RSV-induced proinflammatory
mediator production. To investigate the effect of increasing intra-
cellular H2S levels on viral responses, we determined levels of cyto-
kine and chemokine secretion in A549 cells infected with RSV in the
presence or absence of GYY4137, a slow-releasing H2S donor. A549
cells were infected with RSV for 1 h, followed by incubation with
FIG 1 Effect of RSV infection on H2S production in airway epithelial cells. A549 cells were infected with RSV for 6, 15, and 24 h and harvested to prepare total
RNA or total cell lysates. (A and C) CSE (A, left) and SQOR (C) mRNA levels in uninfected and RSV-infected cells were measured by reverse transcriptase
quantitative PCR (qRT-PCR). CSE cellular levels were also measured by Western blotting of total cell lysates. The membrane was stripped and reprobed for
-actin to determine equal loading of the samples (A, middle). Densitometric analysis of CSE band intensity, normalized to -actin, was performed by using
Alpha Ease software version 2200 (2.2d) (Alpha Innotech Co., San Leandro, CA) (A, right). Results are representative of data from three independent experi-
ments. *, P	 0.05 compared to uninfected cells. (B) A549 cells were infected with RSV for 15 h and harvested to prepare total cell lysates. H2S production in
uninfected andRSV-infected cells was determined by amethylene blue colorimetric assay. Results are representative of data from three independent experiments.
*, P	 0.05 compared to uninfected cells. (D) A549 cells were incubated with 5 M the fluorescent probe SF7-AM and infected with RSV for 1 h. Medium or 10
mM GYY4137 was added to uninfected or infected cells and incubated for 15 h. (Left) Images of uninfected and untreated cells (control) and uninfected or
infected cells treated with 10mMGYY4137. (Right) Average fluorescence intensity quantified by confocal microscopy using Zeiss Metamorph software. Results
are representative of data from three independent experiments. *, P	 0.05 compared to uninfected, treated cells.
Li et al.
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different concentrations ofGYY4137, andharvested to collect the cell
supernatantat24hp.i. tomeasureproinflammatorymediator release
by ELISAs and Bio-Plex assays. RSV-induced secretion of several cy-
tokines and chemokines, such as IL-6, IL-8, RANTES, macrophage
inflammatory protein 1 (MIP-1), and interferon-induced protein
10, was decreased by GYY4137 treatment in a dose-dependentman-
ner (Fig. 3A). To investigate possibleGYY4137 cytotoxicity, superna-
tants of uninfected or infected and treated or untreated A549 cells
were harvested and tested for LDH release. There was no enhanced
cellular damage; on the contrary, we observed a protective effect
against virus-inducedcytotoxicity in response toGYY4137 treatment
(Fig. 3B). Inhibition of proinflammatory secretion, following RSV
infection, by GYY4137 administration was also confirmed in SAE
cells, normal human AECs, which we have shown to behave very
similarly to A549 cells in terms of chemokine/cytokine gene expres-
sion and transcription factor and signaling pathway activation in re-
sponse to RSV infection (12, 19, 22, 28–31) (Fig. 4).
Effects of H2S treatment on RSV replication. To determine
whether increasing intracellular H2S levels affect viral replication,
A549 cells were treated with different concentrations of GYY4137
either 1 h prior to RSV adsorption, until adsorption but not dur-
ing infection, or 1 h after RSV adsorption and throughout infec-
tion and harvested at 24 p.i. to measure viral titers by a plaque
assay. Therewas no change in viral titers whenGYY4137was given
before infection (data not shown), while there was a significant
decrease in RSV replication when GYY4137 was added after ad-
sorption, in particular with the highest dose of the H2S donor, in
the order of a several-log reduction (Fig. 5, left), indicating signif-
icant antiviral activity of H2S administration. To investigate
whether this effect was reproducible if GYY4137was administered
several hours after infection, A549 cells were treated at 3 and 6 h
p.i. andharvested tomeasure viral titers.Weobserved a significant
decrease in RSV replication with both treatments, although the
decrease was somewhat less striking than that with administration
at 1 h p.i. (Fig. 5, middle and right), indicating that GYY4137 can
affect viral replication when infection is already established.
H2S treatment affects virus particle release and syncytium
formation. To further investigate how H2S treatment affected vi-
ral replication, we used several approaches, including quantifica-
tion of viral gene transcription, genome replication, viral antigen
detection, and viral particle release. GYY4137 administration did
not decrease the number of RSV genome copies and N gene cop-
ies; on the contrary, they were somewhat increased at all concen-
trations tested (Fig. 6A and B). Viral protein expression, assessed
by a Western blot assay of total cell lysates, was not significantly
affected byGYY4137 treatment at any of the doses tested (Fig. 6C).
When viral titers were assessed separately on cell supernatants and
cell pellets, we found that GYY4137 administration dramatically
reduced the number of infectious virus particles present in the cell
supernatant, with a much less robust effect on those associated
with the cell pellet (Fig. 6D, left versus right), suggesting that H2S
treatment affects viral replication in part at the level of virus as-
sembly but mostly at the level of virus release. When viral replica-
tion was assessed in a multicycle replication system, this resulted
in a significant inhibition of the cell-associated virus content in
addition to the almost complete absence of virus in the cell super-
natant of infected cells treated with the higher dose of GYY4173
(Fig. 6E). To determine whether the reduction in viral titers in cell
supernatantswas due to fewer virus particles released or to a loss of
infectivity, we performed aWestern blot analysis of viral proteins
in supernatants from cells infected in the absence or presence of
GYY4173. We found clear decreases in the levels of most of the
FIG 2 Effect of CSE inhibition on RSV-induced cytokine and chemokine production and viral replication. A549 cells were infected with RSV for 1 h and then
incubated in the presence or absence of 20 or 40 mM PAG. (A) Cell supernatants from uninfected and RSV-infected cells, treated or untreated, were assayed at
24 h p.i. for cytokine and chemokine secretion by a Bio-Plex assay. Results are expressed asmeans
 standard errors. Results are representative of data from three
independent experiments run in triplicate. (B) Cells were treated as described above for panel A and harvested at 24 h p.i. to determine viral titers by a plaque
assay. *, P	 0.05 compared to untreated RSV-infected cells.
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viral proteins, with the exception of the G protein, which repre-
sents in good part a secreted protein (Fig. 6F). Moreover, we
observed a striking reduction in cellular syncytium formation,
suggesting that GYY4137 treatment can significantly affect virus-
induced cellular fusion (Fig. 6G).
Effect of GYY4137 on RSV-induced cellular signaling. Cyto-
kine and chemokine gene expression inA549 cells infected byRSV
is orchestrated by the activation of the two key transcription fac-
tors NF-B and IRF-3. To determine whether changes in RSV-
induced cytokine and chemokine production observed with
GYY4137 treatment affected NF-B- and IRF-3-dependent gene
transcription, we performed reporter gene assays. Cells were tran-
siently transfected with either a NF-B- or IRF-driven luciferase
reporter plasmid and then treated with GYY4137 after 1 h of viral
adsorption and harvested at 24 h p.i. tomeasure luciferase activity.
RSV infection significantly enhanced both IRF-3- and NF-B-
dependent gene transcription, which was significantly inhibited
by GYY4137 treatment in a dose-dependent manner (Fig. 7A and
B), consistent with the observed reduction in IL-8 and RANTES
secretion.
To determine whether GYY4137 treatment was able to modu-
late virus-induced NF-B and IRF-3 activation, A549 cells were
infected with RSV for 1 h, incubated with or without GYY4137,
and harvested at 15 and 24 h p.i. to prepare either total cell lysates
or nuclear extracts. NF-B and IRF-3 nuclear levels or cellular
levels of phosphorylated serine in p65, the major NF-B subunit
activated in response to RSV infection (22), were assessed by
Western blotting. Nuclear translocation of both transcription fac-
tors was not changed by GYY4137 treatment compared to RSV
infection alone (Fig. 7C); however, therewas a significant decrease
in RSV-induced p65 Ser276 and Ser536 phosphorylation (Fig.
7D), two important posttranslational modifications that affect
NF-B transcriptional activity (32). In addition, GYY4137 treat-
ment significantly reduced p65 and IRF occupancy of their cog-
nate binding site on the IL-8 and RANTES endogenous promot-
ers, assessed by a two-step chromatin immunoprecipitation
(XChIP) and genomic PCR (Q-gPCR) assay (Fig. 7E). Taken to-
gether, these results indicate that increasing cellular H2S levels by
using a slow-releasing donor can effectively modulate the strong
proinflammatory cellular response induced by RSV infection
through blocking IRF- and NF-B-dependent gene transcription.
Effects of H2S treatment on chemokine production and viral
replication induced by other paramyxoviruses. To investigate
whether GYY4137 had similar antiviral and anti-inflammatory
FIG3 Effect ofH2S donor treatment onRSV-induced cytokine and chemokine production inA549 cells. Cells were infectedwith RSV for 1 h and then incubated
in the presence or absence ofGYY4137 at 1, 5, and 10mMfor 24 h.Cell supernatantswere assayed for cytokine and chemokine secretion by anELISAor aBio-Plex
assay (A) and for cytotoxicity by an LDH release assay (B). Results are expressed as means
 standard errors and are representative of data from at least three
independent experiments run in triplicate for the experiments described above for panel A. *, P	 0.05 compared to untreated RSV-infected cells.
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effects on other paramyxoviruses, we measured chemokine secre-
tion and viral replication in A549 cells in response to hMPV in-
fection. A549 cells were infected with hMPV for 1 h and incubated
in the presence or absence of GYY4137 for a total of 24 h. Cell
supernatants were collected to measure levels of IL-8 and
RANTES induction by an ELISA, while viral titers were deter-
mined by immunostaining. hMPV-induced IL-8 and RANTES
secretion was significantly decreased by GYY4137 treatment in
a dose-dependent manner (Fig. 8A). Similarly, viral replication
was also significantly reduced by GYY4137 treatment (Fig. 8B).
A similar experiment was conducted by using a model of SAE
cells infected with NiV-B. Similarly to RSV and hMPV,
GYY4137 treatment led to a significant reduction of virus-in-
duced cytokine and chemokine secretion (Fig. 9A) and inhibi-
FIG 4 Effect of H2S donor treatment on RSV-induced cytokine and chemokine production in SAE cells. Cells were infected with RSV for 1 h and then incubated
in the presence or absence of GYY4137 at 5 and 10mM for 24 h. Cell supernatants were assayed for cytokine and chemokine secretion by an ELISA or a Bio-Plex
assay. Results are expressed asmeans
 standard errors and are representative of data from three independent experiments run in triplicate. *,P	 0.05 compared
to untreated RSV-infected cells.
FIG 5 Effect of H2S donor treatment on RSV replication. A549 cells were infected with RSV for 1, 3, or 6 h and then incubated in the presence or absence of
GYY4137 at 5 and 10 mM for 24 h. Cells were harvested to determine viral titers by a plaque assay. Results are expressed as means 
 standard errors and are
representative of data from five independent experiments run in triplicate. *, P	 0.05 compared to untreated RSV-infected cells.
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tion of viral replication (Fig. 9B). In addition, GYY4137 treat-
ment inhibited syncytium formation in response to both
hMPV and NiV infection (data not shown), suggesting that
GYY4137 has a broad antiviral effect on paramyxoviruses.
DISCUSSION
In this study, we investigated the role of H2S in airway epithelial
cell responses to viral infection. Paramyxoviruses, in particular
RSV and hMPV, are a primary cause of severe lower respiratory
tract infections in children as well as in other populations, leading
to increased morbidity and mortality, for which there is no vac-
cine or treatment besides supportivemeasures. The virus-induced
lung inflammatory response, triggered by the secretion of cyto-
kines and chemokines from virus-infected airway-resident cells
such as AECs and alveolar macrophages, plays an important role
in disease pathogenesis. We and others have shown that modula-
tion of the inflammatory response is associated with an ameliora-
tion of clinical illness in animal models of RSV infection (33–36),
making it an important target for the development of effective
treatment strategies.
H2S is an important endogenous gaseous mediator that has
recently been the focus of intense investigation, leading to sup-
FIG 6 Effect of H2S donor treatment on different steps of viral replication. A549 cells were infected with RSV for 1 h and then incubated in the presence or
absence of GYY4137 for 24 h. (A to C) Cells were harvested to prepare either total RNA tomeasure viral genome copy numbers (A) or RSVN gene copy numbers
(B) by qRT-PCR or total cell lysates to measure viral protein expression by Western blotting (C). The membrane was stripped and reprobed with -actin as a
control for equal loading of the samples. Data are representative of data from three independent experiments with similar results. (D) A549 cells were infected
withRSV for 1 h and then incubated in the presence or absence ofGYY4137 at 5 and 10mM for 24 h. Cell supernatants (left) and cell pellets (right) were harvested
separately to determine viral titers by a plaque assay. Results are expressed as means
 standard errors and are representative of data from three independent
experiments run in triplicate. *, P	 0.05 compared to untreated RSV-infected cells. (E) HEp-2 cells were infected with RSV at anMOI of 0.01 in the presence or
absence of GYY4137 at 5 and 10mM for 48 h. Cell supernatants (left) and cell pellets (right) were harvested separately to determine viral titers by a plaque assay.
Results are expressed as means
 standard errors and are representative of two independent experiments run in triplicate. *, P	 0.05 compared to untreated
RSV-infected cells. (F) A549 cells were infected with RSV for 1 h and then incubated in the presence or absence of GYY4137 for 24 h. Cell supernatants were
harvested to measure viral protein expression by Western blotting. Data are representative of data from two independent experiments with similar results. (G)
Light microscopy photograph (magnification, 20) of HEp-2 cells infected with RSV at an MOI of 0.01 for 48 h in the presence (right) or absence (left) of
GYY4137 at 10 mM. The arrow indicates one of the many syncytia present in the cell monolayer as a result of viral infection.
Li et al.
5564 jvi.asm.org May 2015 Volume 89 Number 10Journal of Virology
 o
n
 June 3, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
portive evidence that it plays an important role in vasoactive, cy-
toprotective, anti-inflammatory, and antioxidant cellular re-
sponses (reviewed in reference 37). Our study shows for the first
time thatH2S has a protective role in RSV infection bymodulating
both inflammatory gene expression and viral replication. AECs
infected with RSV displayed a decreased ability to generate H2S
and enhanced degradation ofH2S released by the donorGYY4137,
indicating that viral infection leads to changes in H2S cellular
homeostasis. Endogenous H2S production appears to play an im-
portant role in modulating virus-induced chemokine secretion
and viral replication, as both were significantly enhanced by treat-
ment of AECs with the CSE inhibitor PAG, while increased H2S
cellular levels, as a result of the administration of GYY4137, were
associated with a significant reduction of proinflammatory medi-
ator production and, most importantly, a striking reduction of
late-stage viral replication.
GYY4137 administration resulted in a strong inhibition of viral
replication at a step subsequent to viral adsorption. It dramatically
reduced the amount of infectious virus present in the cell super-
natant, with a much less robust effect on cell-associated virus,
without having a significant effect on viral gene transcription, pro-
tein synthesis, or genome replication. These findings suggest that
FIG 7 Effect of H2S donor treatment on virus-induced signaling. (A and B) A549 cells were transiently transfected with an ISRE-driven (A) orNF-B-driven (B)
reporter gene plasmid, infected with RSV for 1 h, and then treated with 5 and 10 mMGYY4137. Cells were harvested at 15 or 24 h p.i. to measure luciferase and
-galactosidase reporter activities. Luciferase activitywas normalized to the activity of the internal control-galactosidase. Results are representative of data from
three independent experiments run in triplicate. Data are expressed as means 
 standard errors for normalized luciferase activity. *, P 	 0.05 relative to
untreated, RSV-infected cells. (C) A549 cells were infected with RSV for 1 h, followed by GYY4137 treatment at different concentrations, and harvested at 15 and
24 h p.i. to prepare either total cell lysates or nuclear extracts. IRF-3 and p65 nuclear translocation was assessed by Western blotting of nuclear extracts.
Membranes were stripped and reprobed with lamin B to determine equal loading of the samples. (D) Total Ser276 and Ser536 p65 phosphorylation levels were
determined by Western blotting of total cell lysates. The membrane was stripped and reprobed for total p65 and -actin to determine equal loading of the
samples. Data are representative of data from three independent experiments with similar results. (E) Chromatin DNA from uninfected and RSV-infected A549
cells in the presence or absence of GYY4137 for 15 h was immunoprecipitated by using an anti-NF-B antibody (left), an anti-IRF-3 antibody (right), or IgG as
a negative control. Q-gPCR was performed by using primers spanning either the NF-B-binding site of the IL-8 promoter or the ISRE-binding site of the
RANTES promoter. Total input chromatin DNA for immunoprecipitation was included as positive control for Q-gPCR amplification. The fold change was
calculated compared to the IgG control. Results are representative of data from two independent experiments. *, P	 0.05 relative to untreated, RSV-infected
cells.
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H2S treatment inhibits viral replication in part at the level of virus
assembly but mostly at the level of virus release, which in part
explains the increases in cellular viral mRNA and genomic RNA
levels observed with H2S treatment. To produce progeny virions,
ribonuclear protein complexes, which form cytoplasmic inclu-
sions and contain newly synthesized genomic RNA together with
several viral proteins translated in the cytoplasm, have to be as-
sembled with the surface glycoproteins that have trafficked to the
cell surface through the secretory pathway and are then released to
form mature infectious virus (reviewed in reference 38). The api-
cal recycling endosome (ARE) has been implicated in RSV protein
trafficking and membrane scission, and downregulation of spe-
cific proteins such as myosin Vb or Rab11 disrupts virion forma-
tion and results in diminished numbers of viral progeny. To date,
it is not known whether H2S, or any other endogenous gaseous
transmitters, modulates ARE functions. The final step in viral as-
sembly and budding involves a membrane scission event to sepa-
rate the assembled viral particle from the host cell membrane,
which often involves multivesicular body formation and the en-
dosomal sorting complex required for transport (ESCRT) protein
system, with membrane scission being performed by the ATPase
Vps4 (38). In the case of RSV, budding is unaffected by the inhi-
bition of Vps4, suggesting that RSV uses a novel mechanism for
this final step of replication. Some evidence suggests that surface
glycoproteins, both F and G, could actively contribute to the bud-
ding process leading to RSV egress from infected cells (38). Al-
though we did not detect significant changes in the levels of ex-
pression of most viral proteins, we have not investigated whether
H2S treatment could affect their routing to the cell membrane.
Changes in the cellular localization of the F protein, for example,
could explain the changes observed in syncytium formation and
assembly/release following H2S treatment.
Endogenous H2S production and exogenous H2S administra-
tion have been associated with both proinflammatory and anti-
inflammatory effects in various models of disease (reviewed in
reference 39). In the context of acute pancreatitis and in burn
injury, for example, H2S seems to play a proinflammatory role,
while in other pathologies, such as asthma, COPD, LPS-induced
inflammation, and ischemia reperfusion, it displays anti-inflam-
matory properties. In models of lung injury, administration of
H2S donors has often been associated with an anti-inflammatory
effect. For example, in a mouse model of hyperoxia, treatment
with NaHS was associated with reduced lung permeability and
inflammation, due to decreased levels production of proinflam-
matory mediators such as IL-1, monocyte chemoattractant pro-
tein 1 (MCP-1), and MIP-2 and increased levels of anti-inflam-
FIG 8 Effect of H2S donor treatment on hMPV-induced chemokine production and viral replication. A549 cells were infected with hMPV for 1 h, followed by
treatment with different millimolar concentrations of GYY4137. (A) Cell supernatants from uninfected and hMPV-infected cells, treated or untreated, were
assayed at 24 h p.i. for cytokine and chemokine secretion by a Bio-Plex assay. Results are expressed asmeans
 standard errors. Results are representative of data
from two independent experiments run in triplicate. *, P 	 0.05 compared to untreated hMPV-infected cells. (B) Viral replication was determined at 24 h
postinfection by titration of viral infectious particles released into the cell supernatants by a plaque assay. Results are representative of data from two independent
experiments run in triplicate. *, P	 0.05 compared to untreated hMPV-infected cells.
FIG 9 Effect of H2S donor treatment on NiV-induced chemokine production and viral replication. SAE cells were infected with NiV at an MOI of 0.1 for 1 h,
followed by treatment with a 5mM concentration of GYY4137. (A) Cell supernatants from uninfected andNiV-infected cells, treated or untreated, were assayed
at 24 h p.i. for cytokine and chemokine secretion by a Bio-Plex assay. Results are expressed as means
 standard errors. Results are representative of data from
two independent experiments run in triplicate. *, P	 0.05 compared to untreated NiV-infected cells. (B) Viral replication was determined at 24 h postinfection
by titration of viral infectious particles released into cell supernatants by a plaque assay. Results are representative of data from two independent experiments run
in triplicate. *, P	 0.05 compared to untreated NiV-infected cells.
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matory cytokine expression (40). Similar results were obtained in
other models of acute lung injury, such as the one associated with
hemorrhagic shock or with bleomycin treatment (41, 42).
Recent studies have established that H2S is indeed a biolog-
ically relevant signaling molecule, similar to the other gaseous
mediators nitric oxide and carbon monoxide (reviewed in ref-
erence 43). In several models of inflammatory diseases, the
inhibition of proinflammatory mediator expression was paral-
leled by the inhibition of NF-B activation. NaHS administra-
tion inhibited NF-B activation in a mouse model of hemor-
rhagic shock as well as in a rat model of acute lung injury.
Similarly, H2S donor treatment in a rat model of bleomycin-
induced pulmonary inflammation and fibrosis led to the inhi-
bition of activation of the NF-B subunit p65 (44). In vitro,
NaHS and GYY4137 have been shown to inhibit LPS-induced
NF-B activation in cultured macrophages (5). Garlic com-
pounds such as diallyl sulfide, a possible H2S donor, can also
downregulate NF-B activation (41). GYY4137 treatment of
AECs infected with RSV did not change primary virus-induced
activation of IRF-3 and NF-B, as shown by the lack of changes
in their nuclear translocation, in agreement with the absence of
differences due to GYY4137 treatment in viral RNA generation,
the major trigger of cellular signaling in RSV-infected cells
through the activation of the virus-sensing cytosolic receptor
RIG-I (45). GYY4137 treatment, however, significantly re-
duced IRF-3 and NF-B binding to RANTES and IL-8 endog-
enous promoters, indicating a direct effect of H2S on cellular
signaling. An important mechanism by which H2S can modu-
late cellular signaling is through its direct and indirect antiox-
idant activity (reviewed in reference 43). Administration of
H2S has been shown to increase cellular glutathione levels, and
it has also been associated with increased activation of Nrf2, a
transcription factor that regulates oxidative stress by affecting
the gene expression of several key antioxidant enzymes (43).
Inducible phosphorylation on distinct serine residues, includ-
ing Ser276 and Ser536, has been shown to regulate NF-B tran-
scriptional activity without modification of nuclear transloca-
tion or DNA-binding affinity (32). We have recently shown
that the inhibition of RSV-induced reactive oxygen species
(ROS) formation by treatment of AECs with antioxidants sig-
nificantly reduces RSV-dependent NF-B serine phosphoryla-
tion, resulting in the inhibition of RSV-induced expression
of several NF-B-dependent genes without affecting nuclear
translocation (46). Our finding that H2S treatment signifi-
cantly reduced p65 Ser276 and Ser536 phosphorylation sug-
gests that modulation of ROS cellular levels could be a major
mechanism by which H2S affects virus-induced cellular
signaling.
In conclusion, we have shown that modulation of cellular H2S
significantly impacts cellular responses and viral replication in an
in vitromodel of RSV infection. Our finding that H2S donor treat-
ment also affects replication and proinflammatory mediator pro-
duction in a model of hMPV and NiV infection suggests that H2S
possesses broad antiviral activity against paramyxoviruses.We are
currently investigating the effect of H2S donor treatment in the
context of other nonparamyxovirus infections to determine the
potential antiviral spectrum of these compounds. We are also de-
termining the role of endogenous H2S production in RSV infec-
tion in vivo, taking advantage of knockout mice available for the
enzymes CSE and CBS. Indeed, preliminary studies indicate that
CSE is an important modulator of disease and airway hyper-
responsiveness as well as lung inflammation triggered by RSV in-
fection (A. Casola, unpublished data), similar towhatwas recently
reported for allergic airway inflammation triggered by ovalbumin
sensitization in mice (47). Of interest is the observation that pre-
mature infants, who are at high risk of developing severe bronchi-
olitis following RSV and other respiratory viral infections, have
very low tissue CSE activity compared to full-term infants (48).
We are also evaluating the efficacy of H2S donors in a mouse
model of RSV infection to determine whether their administra-
tion has therapeutic potential for the prevention and treatment of
virus-induced lung disease.
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